Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Shapiro
Samuel
S
D001943:Breast Neoplasms / Q000139:chemically induced*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006291:Health Policy; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008593:Menopause; D011372:Progestins / Q000009:adverse effects*; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced*
D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D011372:Progestins